Yali Friedman, PhD’s Post

Did you know that the fight against global heart disease is being bolstered from cutting-edge corners of the pharmaceutical world? At Dharaa International, our development of APIs (Active Pharmaceutical Ingredients) specifically for cardiovascular treatments is driving significant advancements in healthcare outcomes worldwide. 💓 Through stringent safety protocols and innovative research, we strive to ensure that our APIs are not only effective but also accessible to healthcare providers globally. How do you see the role of pharmaceutical advancements in your local healthcare solutions? Let's discuss!💡 . . . #GlobalHealth #CardiovascularHealth #Pharmaceuticals #InnovationInHealthcare

🌟 LAST WEEK IN PHARMA 🌟 Exciting developments in the pharmaceutical industry! Here are the highlights: M&A News: 🔹 US pharma major Eli Lilly and Company announced a $3.2 billion bid to acquire Morphic Therapeutic. This move will expand Lilly’s IBD pipeline with Morphic’s lead asset MORF-057, currently in Phase II trials for #ulcerative colitis and #Crohn’s disease. Research Updates: 🔹 HilleVax reported disappointing Phase IIb results for its #norovirus vaccine HIL-214, leading to halted development in infants. 🔹 Dutch firm uniQure pleased investors with early-stage results for its #Huntington’s disease drug AMT-130, shifting focus to #regulatory approval. 🔹 Pfizer is progressing with its #Parkinson’s disease candidate danuglipron, selecting an extended release formulation for once-daily dosing. Join the conversation and stay updated on the latest in the #pharmaindustry! Connect, Repost & Follow for more info on the #pharmaceutical industry 🌍 #norovirus #HuntingtonsDisease #ParkinsonsDisease #EliLilly #Morphic #HilleVax #uniQure #Pfizer

📢 𝗦𝘁𝗮𝘆 𝗜𝗻𝗳𝗼𝗿𝗺𝗲𝗱: 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗡𝗲𝘄𝘀 𝗥𝗼𝘂𝗻𝗱𝘂𝗽 📢 9th Oct 2024 - Discover the latest advancements in the pharmaceutical industry with our daily news update. Our roundup includes crucial FDA designations, innovative drug developments, and impactful clinical trial outcomes analysis. Stay ahead and grow faster. #pharmanews #biopharma #fdaapprovals #clinicaltrials #drugdevelopment #pharmadaily #thelansis #Noncirrhoticmetabolicdysfunctionassociatedsteatohepatitis #MASH #Amyotrophiclateralsclerosis #ALS #Influenza #AtopicDermatitis #AD 

Research and development shouldn’t stop at product launch.🔎 At Colonis Pharma, R&D continues long after our products reach patients. Over time, this helps us expand the number of indications and find the most suitable formulations, which means more patients can benefit from our treatments. Hear from Colonis MD Andrew Trouton and Commercial Director Michael Dobson below on our continual investment in value-added medicines. #Pharmaceuticals #Pharma #ValueAddedMedicines

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐓𝐨 2031/ Global Insight Services The global pharmaceutical drug delivery market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 3.3 billion by 2031, at a CAGR of 4.2% during the forecast period. The pharmaceutical drug delivery systems consist of various forms, including controlled-release and oral delivery systems. They can help maximize therapeutic efficacy by controlling drug pharmacokinetics, reducing toxicity, increasing accumulation at the target site, as well as improving patient compliance and acceptance. Visit the following link to request free sample pages https://lnkd.in/e-hvcsuD #pharmaceuticals #pharmaceuticaldrugdelivery #pharma #healthcare #drug #pharmaceuticaldrugdeliverymarket #pharmadrugdeliverymarket 𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 Johnson & Johnson  Novartis  F. Hoffmann-La Roche Ltd Pfizer Bayer Consumer Care AG Antares Pharma Inc. BD GSK 3M Merck

Attractive Opportunities in the GLP-1 Analogues Market Download PDF Brochure https://lnkd.in/d8_4udQs The global GLP-1 Analogue market is expected to reach USD 471.1 billion by 2032 from USD 47.4 billion in 2024, at a CAGR of 33.2% during the forecast period. Novo Nordisk Eli Lilly and Company Sanofi AstraZeneca Jiangsu Hansoh Pharmaceutical Group Co., Ltd. #GLP1Analogue #DiabetesTreatment #Pharmaceuticals #HealthcareIndustry #MarketAnalysis #MedicalResearch #IncretinTherapy #DrugDevelopment #ClinicalTrials #Endocrinology #HealthTech #PatientCare #InsulinResistance #MetabolicDisorders #RegulatoryApprovals #Biopharmaceuticals #TherapeuticInnovation #HealthEconomics #ChronicDiseases #GlobalMarketTrends

Conquer Oncology API Manufacturing Challenges with Seqens!   📅 Join our webinar on October 2nd at 5 PM CET: How to solve the specific manufacturing challenges associated with small molecules Active Pharmaceutical Ingredients (APIs)? 💊   Are you a pharmaceutical company developing innovative small molecule oncology drugs? These complex molecules often require specialized expertise and capabilities in manufacturing. @Seqens is here to help. We've invested in cutting-edge facilities and a team of experts to address the unique challenges associated with potent oncology APIs.   In this webinar, you'll discover: ➡️How to manage low Occupational Exposure Limits for the manufacturing of Potent active ingredients and intermediates ➡️Case studies on handling potent chemicals: from lab scale to process industrialization ➡️Insights on our new capacities for manufacturing anticancer Active Pharmaceutical Ingredients, with highly potent and potent capabilities    Register now and secure your spot! ➡️ [https://lnkd.in/dpxe9Prg] #Seqens #OncologyAPIs #SmallMolecules #PharmaManufacturing #Webinar

CPHI now heads to South-East Asia,giving pharmaceutical industry to converge, and opening new avenues for collaboration and innovation in pharmaceutical advancements, regulatory insights, and healthcare solutions. Our team will be at CPHI South-East Asia for dynamic discussions, strategic partnerships, and groundbreaking solutions that propel the Pharma Industry forward. #IOLCP #AlliedandCommitted #SpecialtyChemicals #API #Pharmaceutical #Pharmaceuticalindustry #CPHISouthEastAsia2024 #CPHI #CPHI #SouthEastAsia

How Pharmaceutical Intermediates Drive Innovation in Drug Development: Pharmaceutical intermediates may not make the headlines, but they’re the unsung heroes behind every life-saving drug. Here’s why they’re critical: 1️⃣ Essential Building Blocks Intermediates are the foundation for creating Active Pharmaceutical Ingredients (APIs), enabling the development of everything from antibiotics to anticancer treatments. 2️⃣ Speeding Up Drug Development High-quality intermediates simplify complex synthesis processes, helping companies bring innovations to market faster. 3️⃣ Versatile Applications Whether it’s cardiovascular drugs or antiviral treatments, pharmaceutical intermediates play a pivotal role in meeting diverse therapeutic needs. At S. Nihar Exports, we ensure the highest standards in our intermediates, so your research and production stay ahead of the curve. Ready to explore how we can support your projects? Let’s connect—I’d love to discuss your needs! #Pharmaceuticals #PharmaceuticalIntermediates #DrugDevelopment #Innovation #API #ChemicalIndustry #ResearchAndDevelopment #Chemicals

🔬 Exciting New Pharmaceutical Products Available! 🔬 Looking for cutting-edge pharmaceutical products to enhance your research or drug development efforts? We have two remarkable offerings that are sure to grab your attention: Product 1: (R)-3-aminopiperidine dihydrochloride - CAS number: 334618-23-4 - Molecular formula: C5H14Cl2N2 - Molecular weight: 173.08 - Usage: This compound belongs to the family of synthetic dipeptidyl peptidase IV (DPP-IV) inhibitors. Known for their role in diabetes medications, DPP-IV inhibitors like Sitagliptin and Alogliptin are widely used to regulate blood sugar levels effectively. Product 2: - CAS number: 98977-36-7 - Molecular formula: C10H17NO3 These high-quality products hold immense potential for advancing your scientific endeavors. Whether you're conducting groundbreaking research or developing innovative pharmaceutical solutions, these compounds can be invaluable assets in your quest for success. Get in touch with us today to inquire about availability, pricing, and any additional information you may require. Our team of experts is ready to assist you in harnessing the power of these extraordinary compounds. Stay ahead of the curve and propel your scientific achievements to new heights with these remarkable additions to your laboratory! #Pharmaceuticals #Research #Innovation #Science #DrugDevelopment #DiabetesMedications